Biotechnology drug

Author: Ma Dalong
Publisher:
Publish Date: 2003-04-01
Features: This book is one of the series "863 Biotechnology High-Tech Series." Biotechnology drugs include cell clusters, recombinant protein drugs, antibodies, vaccines, and oligonucleotide drugs, which are primarily used to prevent and treat difficult diseases such as tumors, cardiovascular diseases, infectious diseases, asthma, diabetes, genetic diseases, cardiovascular and cerebrovascular diseases, and rheumatoid arthritis. They have already been widely applied in clinical practice, bringing revolutionary changes to the pharmaceutical industry. Since the implementation of the "863" program in China in 1986, research, development, and industrialization of biotechnology drugs have achieved rapid progress. This book combines the achievements of Chinese scientists in the research and development of biotechnology drugs, introduces the research progress and development trends of biotechnology drugs internationally over the past 20 years, and proposes ideas for China's R&D strategy in this field. The book aims to popularize knowledge about biotechnology drugs, inspire new ideas for research and development, and promote the industrialization process of pharmaceutical biotechnology in China. It is suitable for researchers, graduate students, industry professionals, and others interested in this field.